| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,796 |
1,515 |
$281K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,363 |
2,172 |
$98K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
468 |
375 |
$84K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
243 |
219 |
$75K |
| 36415 |
Collection of venous blood by venipuncture |
5,157 |
4,569 |
$64K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
877 |
830 |
$57K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
958 |
857 |
$28K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
475 |
462 |
$27K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
457 |
442 |
$24K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
163 |
160 |
$22K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
567 |
547 |
$19K |
| 80053 |
Comprehensive metabolic panel |
337 |
319 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
393 |
189 |
$10K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
86 |
83 |
$7K |
| 87634 |
|
60 |
60 |
$7K |
| J3490 |
Unclassified drugs |
532 |
310 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
114 |
103 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
429 |
419 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
69 |
51 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
42 |
38 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
33 |
12 |
$3K |
| 82248 |
|
82 |
79 |
$2K |
| 81001 |
|
97 |
94 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
50 |
49 |
$1K |
| 87430 |
|
85 |
82 |
$998.40 |
| 80061 |
Lipid panel |
26 |
26 |
$995.70 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
15 |
13 |
$415.62 |
| J2704 |
Injection, propofol, 10 mg |
14 |
12 |
$79.08 |
| A9270 |
Non-covered item or service |
45 |
31 |
$0.00 |